Another advice to the Stemson crew, specially to the CEO Geoff Hamilton: go start human trials in the UK and take advantage of the fast track policies there.
The regulatory approval process in the US will take too much time. Stemson doesn't have any revenues and the funds raised won't last forever. If you try to release the treatment in US soil first you risk running out of money before reaching any significant milestone.
Release the treatment in the UK first and as fast as you can.
The regulatory approval process in the US will take too much time. Stemson doesn't have any revenues and the funds raised won't last forever. If you try to release the treatment in US soil first you risk running out of money before reaching any significant milestone.
Release the treatment in the UK first and as fast as you can.